Submissions

Author Guidelines

Editorial Policies and Submission Guidelines

• It is mandatory to provide the ORCID identifier of all authors at the time of submission. If you do not already have one, you can register for free at: https://orcid.org/register.
• Following the approval of the manuscript, no modifications to the author list will be permitted.
• Prior to final publication, the Editorial Team reserves the right to edit the text and visual elements (figures and tables) to ensure linguistic quality, clarity, and adherence to the journal’s style. Proofs will be sent to the corresponding author.
• Manuscripts that do not conform to the journal guidelines, or for which metadata has not been completed accurately during the submission process, will not be considered for publication.
• Manuscripts must be submitted exclusively in Word via the Electronic System, through the link: https://bioscienceshealth.com.br/index.php/bh/about/submissions

Title Page

The title page must be submitted as a separate document and must include the following information:

• Article Title: A concise and informative title English that accurately reflects the content of the manuscript. (Size 17, Calibri (Body), capital letters and words, centered, bold)
• Author Information: The full name and academic or professional affiliation.
• Corresponding Author Details: The name and professional email address of the designated corresponding author.

Author name and academic or professional affiliation should follow the following format:

Jhames Francson HOLL¹, Soares Torres FRANCISCON¹ (Size 14, Calibri Body, centered)

¹Department of Health Sciences, Faculdade de São Paulo, São Paulo, Brazil (Size 12, Calibri Body, justified alignment)

Corresponding Author:
Jhames Francson Holl
jhamesfholl@gmail.com
(Size 12, Calibri Body, justified alignment)

Manuscript Formatting Guidelines
The manuscript file must adhere to the following specifications. All text must be formatted in size 12, Calibri (Body) font, with justified alignment.

• Article Title: A concise and informative title English that accurately reflects the content of the manuscript. (Size 17, Calibri (Body), capital letters and words, centered, bold).
• Abstract: Authors must provide an abstract in English. Each version must be between 150 and 250 words and encompass the theoretical background, objectives, materials and methods, results, and conclusions. The use of undefined abbreviations is strictly prohibited except for widely recognized abbreviations such as pH, mL, DNA and HIV.
• Keywords: Authors must provide 3 to 8 keywords in English, separated by semicolons (;). Keywords must correspond to the official MeSH (Medical Subject Headings) terms.

Manuscript Structure
The manuscript should be organized according to the following sections:

1. Introduction: Provides the theoretical background, defines the research problem, and states the study's objectives.
2. Materials and Methods (or Methodology): Details the procedures and methodological framework employed in the research.
3. Results: Presents the empirical findings of the study.
4. Discussion: Offers an interpretation of the collected data.
• Alternative: Sections 3 and 4 may be combined into a single Results and Discussion section if preferred.
5. Conclusion (or Final Considerations): Summarizes the research findings in a clear and objective manner.

The manuscript file must adhere to the following specifications:

ORIGINAL PAPERS
Title; Abstract; Keywords; Introduction; Materials and Methods; Results; Discussion; Conclusion; Author Contributions; Conflict of Interest Declaration; Funding Disclosure (if any); Ethical Approval (if any); Acknowledgments (if any); References; Appendix (if any).

CLINICAL TRIAL PROTOCOLS
Title; Abstract; Keywords; Introduction; Materials and Methods; Expected Results; Discussion; Conclusion; Author Contributions; Conflict of Interest Declaration; Funding Disclosure (if any); Ethical Approval (if any); Acknowledgments (if any); References; Appendix (if any).

REVIEW ARTICLES
Title; Abstract; Keywords; Introduction; Methodology; Results; Discussion; Conclusion; Author Contributions; Conflict of Interest Declaration; Funding Disclosure (if any); Ethical Approval (if any); Acknowledgments (if any); References; Appendix (if any).

CASE REPORTS
Title; Abstract; Keywords; Introduction; Case description; Results; Discussion; Conclusion; Author Contributions; Conflict of Interest Declaration; Funding Disclosure (if any); Ethical Approval; Acknowledgments (if any); References; Appendix (if any).

Title; Abstract; Keywords; Introduction; Case description; Discussion; Conclusion; Author Contributions; Conflict of Interest Declaration; Funding Disclosure (if any); Ethical Approval; Acknowledgments (if any); References; Appendix (if any)

Tables
All tables must be referenced and inserted into the text in numerical order (Table 1. Table 2. etc.,) with a concise caption. During the submission process, each table must be submitted in a separate file in Microsoft Word using the Table function.

Figures
All figures must be mentioned and inserted in the text in numerical order (Figure 1. Figure 2. etc.) with a concise caption. During the submission process, each figure must be sent as a separate file, using TIFF or JPG format, with a minimum resolution of 300 dpi and a maximum width of 18 cm.

Mandatory manuscript declarations

• Author Contributions: A brief description of the specific contribution made by each author to the manuscript, formatted in accordance with CRediT (Contributor Roles Taxonomy) standards.
• Conflict of Interest Declaration: A formal declaration disclosing any potential financial or non-financial conflicts of interest (governmental, commercial, or non-commercial sources). If no conflicts exist, a statement to that effect is required.
• Funding Disclosure: A comprehensive statement identifying all sources of financial support for the research, including grant numbers where applicable. If no funding was received, this must be explicitly stated. When not applicable, state: “Not applicable”.
• Ethical Approval: Provide the name of the Research Ethics Committee (REC) or the Ethics Committee on the Use of Animals (CEUA), the responsible institution, and the respective approval opinion or protocol number. When not applicable, state: “Not applicable”.
• Acknowledgments: A statement acknowledging any individuals or organizations that contributed to the work but do not qualify for authorship including scholarships (specialization, masters, doctorate, post-doc) with the name of the agency and the protocol number whenever possible. When not applicable, state: “Not applicable”.

References and Citations

In-Text Citations

• System: Use the Vancouver (numerical) style.
• Indirect Citation: BioscHealth exclusively accepts indirect citations (paraphrasing). Authors must integrate the ideas, data, and conclusions of others into their own narrative. Direct quotations are not permitted.
• Numerical Formatting: Citations must be placed in square brackets [n]. Use an en-dash to indicate a range of consecutive references (e.g., [1-3]). For non-consecutive multiple citations, use commas (e.g., [1,5,8]).

Examples of In-Text Citations

Citations in the reference list
Examples:

Journal Article (≤6 authors):
Martins TCP, Koga EBS, Mostaco CD, Lopes LGA, Marcolino CG, Righetto RR. Attendance and service quality in primary care: reflections within Brazil’s Unified Health System. Biosciences and Health. 2024; 2:1-6. https://doi.org/10.62331/2965-758X.v2.2024.65

Journal Article (>6 authors):
Miranda AGV, Biselli FC, Scapin N, Pescaroli JKG, Fernandes LVM, Bortoluzo CL, et al. The role of phytotherapy in women’s intimate health: a narrative review. Biosciences and Health. 2024; 2:1-6. https://doi.org/10.62331/2965-758X.v2.2024.66

Book:
Murray PR, Rosenthal KS, Kobayashi GS, Pfaller MA. Medical Microbiology. 4th ed. Louis: Mosby; 2002.

Book Chapter:
Meltzer PS, Kallioniemi A, Trent JM. Chromosome alterations in human solid tumors. In: Vogelstein B, Kinzler KW, editors. The Genetic Basis of Human Cancer. New York: McGraw-Hill; 2002. p. 93-113.

Preprint:
Alvarez R. Near optimal neural network estimator for spectral x-ray photon counting data with pileup. arXiv:1702.01006v1 [Preprint]. 2017; 1-11 [cited 2024 Jan 15]. Available from: https://arxiv.org/abs/1702.01006

DOI presentation in references
When available, DOIs must be presented exclusively in the format of a permanent URL.

Correct format:
https://doi.org/10.xxxx/xxxxx

Avoid:
DOI: 10.xxxx/xxxxx

Reference List Specifications

• Scope: Only references to published articles or manuscripts formally accepted for publication (in press) may be included.
• Prohibited references: Unpublished data, personal communications, theses, dissertations, monographs, proceedings of scientific events, conference abstracts, and materials that are inaccessible or cannot be verified by readers are not accepted.
• Selection of references: Authors must include only authentic, verifiable, relevant, up-to-date references that are directly related to the content of the manuscript.
• Nonexistent or unverifiable references: The inclusion of nonexistent, incorrect, or unverifiable references, regardless of the tool used for their retrieval, constitutes a serious breach of scientific integrity and may result in manuscript rejection.
• Reference numbering: References must be numbered according to the order of their first appearance in the text.
• Author list: For articles with six authors or fewer, all authors must be listed. For articles with seven or more authors, the first six authors must be listed, followed by “et al.”
• Journal titles: Journal titles must be formatted in italics and abbreviated according to the NLM Catalog.
• Digital identifiers: The DOI should be included for all references when available. If a DOI is not available, the permanent URL of the document should be provided. Authors are encouraged to use the Crossref Simple Text Query tool for metadata retrieval and verification.
• Reference formatting: References must follow the U.S. National Library of Medicine (NLM) recommendations, with specific editorial adaptations established by BioscHealth.
• Maximum number of references: BioscHealth does not impose a maximum number of references; however, all references must be relevant and necessary for the scientific development of the manuscript.
• Correspondence between citations and references: All references included in the reference list must be cited in the text, and all citations appearing in the text must correspond to references included in the final reference list.

Similarity Identification and Plagiarism Prevention and Use of Artificial Intelligence
Plagiarism, whether intentional or unintentional, constitutes a serious ethical violation. Plagiarism is defined as the partial or complete reproduction of content/text from another work without proper attribution through citation. If evidence of plagiarism is identified at any stage of the editorial process (pre-acceptance, post-acceptance, or post-publication), the authors will have the right to a written defense. Should the provided explanations be deemed unsatisfactory, the manuscript will be rejected (if unpublished) or retracted (if already published); the authors will face sanctions, including a prohibition on submitting new articles to the journal for a period determined by the Editor-in-Chief; the case may be reported to the authors’ affiliated institutions. BioscHealth employs the software Plagius - Plagiarism Detector for text similarity detection and plagiarism prevention. Additionally, AI-generated articles, manuscripts produced wholly or partially by AI tools will not be accepted for publication. If AI tools are used for text editing or proofreading in English, this use must be explicitly disclosed in the cover letter.

Copyright, Open Access and Licensing